Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2007-5533
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Unspecified vulnerability in the People Tools component in Oracle PeopleSoft Enterprise and JD Edwards EnterpriseOne 8.47.14, 8.48.13, 8.49.05 has unknown impact and remote attack vectors, aka PSE02.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Oracle PeopleSoft Enterprise和JD Edwards EnterpriseOne People Tools组件安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Oracle PeopleSoft Products和Oracle JD Edwards Products都是美国甲骨文(Oracle)公司的产品。Oracle PeopleSoft Products是一套企业人力资本管理解决方案。该产品提供了人力资本管理、财务管理、供应商关系管理等功能。PeopleSoft Enterprise PeopleTools是其中的一个支持转变企业管理、PeopleSoft软件的使用以及维护方式的工具和技术平台组件。Oracle JD Edwards Products是一套全
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2007-5533
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2007-5533
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2007-5533

No comments yet


Leave a comment